We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Stage II desmoplastic melanoma treated with neoadjuvant immunotherapy and Mohs micrographic surgery.
- Authors
Lewis, Daniel J.; Zhang, Junqian; Elenitsas, Rosalie; Shanti, Rabie M.; Miller, Christopher J.; Cohen, Justine V.
- Abstract
Our patient represents the first reported case of neoadjuvant immune checkpoint inhibitor (ICI) therapy for stage II melanoma. At this time, surgical resection and adjuvant therapy remain the standard of care for high-risk stage II and clinical stage III melanoma.[1] However, appropriate patients can be considered for neoadjuvant therapy in ongoing clinical trials.
- Subjects
MOHS surgery; MELANOMA; IMMUNOTHERAPY; SENTINEL lymph node biopsy
- Publication
Journal of the European Academy of Dermatology & Venereology, 2023, Vol 37, Issue 3, pe433
- ISSN
0926-9959
- Publication type
Article
- DOI
10.1111/jdv.18669